✦ LIBER ✦

A phase I trial of 5-fluorouracil, leucovorin, and dipyridamole given by concurrent 120-h continuous infusions

✍ Scribed by Howard Bailey; George Wilding; Kendra D. Tutsch; Rhoda Z. Arzoomanian; Dona Alberti; Mary B. Tombes; Jean L. Grem; David R. Spriggs

Publisher: Springer
Year: 1992
Tongue: English
Weight: 703 KB
Volume: 30
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf00686299

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cyclophosphamide, methotrexate, and 5-fl

Cyclophosphamide, methotrexate, and 5-fluorouracil in a three-drug admixture. Phase I trial of 14-day continuous ambulatory infusion

✍ Jacob Lokich; Murray Bern; Norwood Anderson; Sabina Wallach; Cherie Moore; Karen 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 321 KB 👁 2 views

Brachytherapy and continuous infusion 5-

Brachytherapy and continuous infusion 5-fluorouracil for the treatment of locally advanced, lymph node negative, prostate cancer: A phase I trial

✍ William A. See; Robert Dreicer; James A. Wheeler; Paula K. Forest; Stefan Loenin 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 405 KB 👁 1 views

BACKGROUND. 5-fluorouracil (5-FU) is a known radiosensitizer that enhances efficacy, in vivo and in vitro, when administered during radiotherapy. The following study was performed to evaluate the toxicity of continuous infusion 5-FU administered concomitant with brachytherapy in patients with locall

A phase I trial of cisplatin in hyperton

A phase I trial of cisplatin in hypertonic saline and escalating doses of 5-fluorouracil by continuous intravenous infusion in patients with advanced malignancies

✍ Leonard Saltz; David Kelsen 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 427 KB 👁 2 views

Phase II trial of 5-fluorouracil, leucov

Phase II trial of 5-fluorouracil, leucovorin, interferon-α-2a, and cisplatin as neoadjuvant chemotherapy for locally advanced esophageal carcinoma

✍ Barbara K. Temeck; James E. Liebmann; Christopher Theodossiou; Seth M. Steinberg 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 635 KB

## BACKGROUND. Most patients with esophageal carcinoma present with locally advanced disease and a poor prognosis. Surgery or radiation provides palliation for locally advanced esophageal carcinoma. The role of neoadjuvant therapy remains to be defined. We administered neoadjuvant chemotherapy cons